MTUS2 inhibitors constitute a class of chemical agents specifically designed to interact with the protein encoded by the MTUS2 gene, known as Mitochondrial Tumor Suppressor 2 (MTUS2). This protein is involved in cellular processes that relate to the maintenance of mitochondrial function and integrity. Mitochondria are organelles within the cell that are often described as the powerhouses of the cell, due to their role in energy production through the process of oxidative phosphorylation. They are also involved in various other key processes, such as signaling, cellular differentiation, and the control of the cell cycle and cell growth. MTUS2 plays a role in regulating these processes, and the precise modulation of MTUS2 function can have significant effects on mitochondrial operations.
Inhibitors targeting MTUS2 are typically small molecules that have been discovered or synthesized to bind to the MTUS2 protein. This binding can alter the normal function of MTUS2, potentially affecting the mitochondrial operations in which it is involved. The development and study of MTUS2 inhibitors require a deep understanding of the protein's structure and the biochemical pathways in which it participates. Advanced techniques in biochemistry and molecular biology, such as mass spectrometry, gene knockdown or knockout studies, and computational modeling, are employed to characterize these inhibitors and to understand their mode of action at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor antagonist. Losartan can block AT2 receptor signaling, potentially affecting the interaction and function of MTUS2 within this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor. MTUS2 has been suggested to modulate PI3K/AKT signaling. Inhibiting PI3K can indirectly influence MTUS2's role in this pathway. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
Akt inhibitor. If MTUS2 is linked with the PI3K/AKT pathway, this inhibitor can modulate the protein's function within this signaling route. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. If MTUS2 operates within JNK signaling, this compound can indirectly modulate its role. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. If MTUS2 has a function in the p38 MAPK pathway, this inhibitor can have an indirect impact. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor. Similar to LY294002, this compound can modulate MTUS2 if it operates within the PI3K signaling route. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor. MTUS2 may have a function related to Rho-associated kinases (ROCK). Inhibiting ROCK can indirectly affect MTUS2's role in this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor. If MTUS2 is linked with mTOR signaling, rapamycin can indirectly modulate the protein's function within this pathway. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
c-Raf inhibitor. As MTUS2 might be associated with RAF/MEK/ERK signaling, inhibiting c-Raf can potentially modulate MTUS2 if it's part of this cascade. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
ERK inhibitor. If MTUS2 operates within the MAPK/ERK pathway, this compound can indirectly influence its function. | ||||||